Chattanooga, TN, United States of America

Advanced Catheter Therapies, Inc.

Calculating rank

USPTO Granted Patents = 6

% Expired Patents = 16.7

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 132

Loading Chart...

3 inventors (with patents filed for the assignee):

Dirk Hoyns (6 out of 11 patents)

C Rex Teeslink (5 out of 5 patents)

Charles Teeslink (1 out of 1 patent)

4. Dirk V Hoyns (0 patent)

5. Dirk V Hoyns (0 patent)

6 patents: Sort by Forward Citations

1. 9526874 - Occlusion perfusion catheter (2016-12-27),

2. 9254145 - Atherectomy device (2016-02-09),

3. 9017285 - Occlusion perfusion catheter (2015-04-28),

4. 8398589 - Occlusion perfusion catheter (2013-03-19),

5. 8262611 - Occlusion perfusion catheter (2012-09-11),

6. 8088103 - Occlusion perfusion catheter (2012-01-03),

Company Overview

Advanced Catheter Therapies, Inc. (ACT) is a medical device company focused on developing innovative catheter-based technologies for the treatment of vascular diseases. Our products provide minimally invasive solutions for patients with a range of conditions, including peripheral artery disease and venous insufficiency. At ACT, we are dedicated to advancing the field of catheter therapies and improving patient outcomes through cutting-edge technology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

6 Patents

#28 in Chattanooga, TN

#477 in Tennessee

#45,027 in US

Chattanooga, TN, United States of America

Advanced Catheter Therapies, Inc.

Forward Citations = 132

3 inventors:

Dirk Hoyns (6 out of 11 patents)

C Rex Teeslink (5 out of 5 patents)

Charles Teeslink (1 out of 1 patent)

4. Dirk V Hoyns (0 patent)

5. Dirk V Hoyns (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Advanced Catheter Therapies, Inc.. Retrieved from https://idiyas.com/company/advanced-catheter-therapies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]